NEM vs NWPX

Newmont Corporation presents a dichotomy between strong operational fundamentals and significant valuation premiums. While the Piotroski F-Score of 4/9 indicates stable health and the balance sheet is pristine with a Debt/Equity ratio of 0.17, the stock trades at a substantial premium to its Graham Number ($66.88) and Intrinsic Value ($44.73). Recent quarterly earnings beats are impressive, yet bearish insider sentiment and a 0/100 technical trend suggest a lack of immediate conviction from internal stakeholders and market momentum. The overall outlook is neutral as strong profitability is offset by overvaluation and negative insider signals.

NWPX exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9 and a very conservative debt-to-equity ratio of 0.28. However, the stock is severely overvalued, trading at $83.84—well above its Graham Number ($57.43) and Intrinsic Value ($24.92). This valuation gap is compounded by negative earnings growth (-9.7% YoY) and a bearish insider sentiment characterized by consistent selling from the CEO and Directors. Despite a rock-solid balance sheet, the divergence between the parabolic price action (+102% 1Y) and deteriorating fundamental growth suggests a high risk of correction.